Submitted by Anonymous (not verified) on 14 November 2025 - 9:45
Human medicines European public assessment report (EPAR): Triumeq, abacavir,dolutegravir,lamivudine, Date of authorisation: 31/08/2014, Revision: 37, Status: Authorised
Source: